Abstract
Objective: To evaluate the clinical efficacy of low-crosslinked hyaluronic acid (HA) injections in the superficial fat layer for facial rejuvenation in Chinese patients.
Methods: A total of 30 patients were treated between July 2023 and October 2024, receiving three sessions of low-crosslinked HA injections spaced one month apart. Injections were administered using a fanning technique into the superficial fat layer. Outcomes were assessed at one and three months post-treatment using smart skin analysis, the Global Aesthetic Improvement Scale (GAIS), and patient satisfaction surveys.
Results: Significant improvements in wrinkles, pore size, and pigmentation were observed. GAIS scores confirmed rejuvenation in all patients, with 100% satisfaction at one month. Adverse effects were minimal, consisting of mild discomfort and rare bruising.
Conclusion: Low-crosslinked HA injection in the superficial fat layer is an effective and safe method for facial rejuvenation.
Introduction
Facial aging is a complex process involving skin dryness, wrinkle formation, sagging, and volume loss. While traditional aesthetic treatments often target the dermis to stimulate collagen, recent research suggests that structural changes in the subcutaneous fat and the retinacula cutis (RC)—the connective fibers supporting the skin—are primary drivers of sagging and contour irregularities. This study explores the efficacy of targeting these deeper layers using low-crosslinked hyaluronic acid (HA) in a Chinese patient cohort.
Methods
The researchers conducted a retrospective study of 30 patients (aged 28–67) exhibiting signs of facial aging. The treatment protocol involved three sessions at one-month intervals.
Physicians used a 25G, 50 mm cannula to inject a low-crosslinked HA gel (Aqua type, Bloomage Biotechnology) into the superficial fat layer. A "fanning technique" was employed to ensure even distribution across the suborbital region, lateral cheek, and perioral area.
Clinical evaluation was performed at one month (M1) and three months (M3) post-treatment using the ALURA LEGEND Smart Skin Analyzer for objective quantification of skin parameters and the Global Aesthetic Improvement Scale (GAIS) for physician assessment.
Key Results
The study demonstrated statistically significant improvements (p < 0.05) across all objective skin metrics:
- Wrinkle Severity: Reduced from 19.56% at baseline to 12.07% at M3.
- Pore Visibility: Improved from 30.01% at baseline to 23.18% at M3.
- Pigmentation: Superficial pigmentation scores dropped from 16.45% to 13.90% at M3.
Physician assessments via GAIS showed that 100% of patients exhibited visible improvement by the three-month mark, with 90% categorized as "much improved" or "very much improved." Patient satisfaction remained high, reaching 93.3% at three months. Safety profiles were excellent; the average pain score was low (3.40 ± 1.55), and minor bruising in two patients resolved within a week.
Discussion and Conclusion
Injecting low-crosslinked HA into the superficial fat layer addresses aging by targeting the structural retinacula cutis. The low degree of crosslinking (0.6%) and small particle size (200 µm) of the HA used provide a scaffold that restores volume and reduces laxity more effectively than standard dermal injections.
While the study is limited by its small sample size and lack of histological data, the results suggest that this technique is a safe and potent alternative for facial rejuvenation. Future research should involve larger, multi-center cohorts and objective measurements of collagen and elastin density to further validate these structural benefits.
Summary updated